Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes

Fig. 2

Scatterplots of apoB versus LDL-C at baseline (a) and following treatment with ERN/LRPT or placebo for 12 weeks (b). The upper thresholds for the less-stringent LDL-C <100 mg/dL and apoB <90 mg/dL goals are denoted by horizontal and vertical lines, respectively. Right lower quadrant shows the large number of subjects who met LDL-C goal <100 mg/dL but did not reach apoB goal <90 mg/dL after niacin treatment

Back to article page